These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10915480)

  • 1. Surface modification of stents for improving biocompatibility.
    al-Lamee K
    Med Device Technol; 2000; 11(1):12-6, 18, 20. PubMed ID: 10915480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
    Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modification of metallic cardiovascular stents by strongly adhering aliphatic polyester coatings.
    Jérôme C; Aqil A; Voccia S; Labaye DE; Maquet V; Gautier S; Bertrand OF; Jérôme R
    J Biomed Mater Res A; 2006 Mar; 76(3):521-9. PubMed ID: 16317721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using ultrasonic spray nozzles to coat drug-eluting stents.
    Berger HL
    Med Device Technol; 2006; 17(9):44-6, 48-9. PubMed ID: 17240688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and surface characterization of HMDI-activated 316L stainless steel for coronary artery stents.
    Chuang TW; Chen MH; Lin FH
    J Biomed Mater Res A; 2008 Jun; 85(3):722-30. PubMed ID: 17896759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of stent design and coatings on restenosis and thrombosis.
    Hara H; Nakamura M; Palmaz JC; Schwartz RS
    Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents: a multidisciplinary success story.
    Burt HM; Hunter WL
    Adv Drug Deliv Rev; 2006 Jun; 58(3):350-7. PubMed ID: 16546288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
    Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design.
    Hezi-Yamit A; Sullivan C; Wong J; David L; Chen M; Cheng P; Shumaker D; Wilcox JN; Udipi K
    J Biomed Mater Res A; 2009 Jul; 90(1):133-41. PubMed ID: 18491390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of drug coating on drug eluting stents].
    Luo LL; Wang GX; Yin TY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility study of plasma-coated nitinol (NiTi alloy) stents.
    Wang G; Shen Y; Cao Y; Yu Q; Guidoin R
    IET Nanobiotechnol; 2007 Dec; 1(6):102-6. PubMed ID: 18035911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of surface microroughness by plasma deposition and chemical erosion followed by TiO2 coating upon anticoagulation, hydrophilicity, and corrosion resistance of NiTi alloy stent.
    Wang GX; Shen Y; Zhang H; Quan XJ; Yu QS
    J Biomed Mater Res A; 2008 Jun; 85(4):1096-102. PubMed ID: 17941010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.
    Hansi C; Arab A; Rzany A; Ahrens I; Bode C; Hehrlein C
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):488-96. PubMed ID: 19235237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
    Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
    J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimicry 1: PC.
    Cumberland DC; Gunn J; Malik N; Holt CM
    Semin Interv Cardiol; 1998; 3(3-4):149-50. PubMed ID: 10406685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.